CONVERSION OF NORMAL RATS INTO SCID-LIKE ANIMALS BY MEANS OF BONE-MARROW TRANSPLANTATION FROM SCID DONORS ALLOWS ENGRAFTMENT OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
I. Lubin et al., CONVERSION OF NORMAL RATS INTO SCID-LIKE ANIMALS BY MEANS OF BONE-MARROW TRANSPLANTATION FROM SCID DONORS ALLOWS ENGRAFTMENT OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Transplantation, 60(7), 1995, pp. 740-747
We have recently shown that lethally irradiated normal strains of mice
, radioprotected with SCID bone marrow, can be engrafted with human pe
ripheral blood mononuclear cells (PBMC), We now demonstrate that letha
lly irradiated Lewis rats can also be radioprotected with a transplant
of SCID bone marrow cells, administered 1 day after total body irradi
ation. Split chimerism was found in PBMC, 30 days after transplantatio
n, with predominance of SCID donor-type cells. The average percentages
of CD4 and CD8 T cells, of mouse or rat origin, were <1%. This chimer
ism status could be maintained for over 3 months, When human PBMC (300
-1000x10(6) cells) were transplanted intraperitoneally 1 day after the
administration of SCID bone marrow, prompt engraftment of human CD4 a
nd human CD8 T cells, as well as human CD20 B cells, was found in the
peritoneum and in internal organs (such as liver, lung, spleen, thymus
, and lymph nodes), T cell activation was high: about 50% of the cells
expressed HLA-DR and almost all expressed CD45RO. High titers of huma
n Ig (>1 mg/ml) were initially found after 2 weeks; these levels were
similar to those found in the irradiated mouse model and in the SCID m
odel. Likewise, marked human antitetanus response, predominantly of th
e IgG type, was recorded 2 weeks after the immunization, reaching maxi
mal levels at 4 weeks, The triple-chimeric SCID-like rats, which accep
t as much as 1000x10(6) human PBMC, can potentially be used to elicit
both antibody responses and T cell responses against specific antigens
, with the advantages of a larger animal.